drugset
drugset / Trial / NCT02224443

Effects of Different Doses of Dexmedetomidine on Postoperative Cognitive Dysfunction in Elderly Hypertensive Patients

NCT02224443 ↗

Phase 4 Unknown 90 enrolled First Affiliated Hospital Xi'an Jiaotong University
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to identify the effects of different doses of dexmedetomidine on postoperative cognitive dysfunction in elderly hypertensive patients

Timeline

Start
2014-09
Primary completion
2015-08
Completion
2015-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.3 ug/kg —
Subject Dexmedetomidine Other / unclassified 0.5 ug/kg —
Background Cisatracurium Small molecule 0.05 mg/kg —
Background Cisatracurium Small molecule 0.1 mg/kg —
Background Cisatracurium Small molecule 0.15 mg/kg —
Background Etomidate Small molecule 1 mg/kg —
Background Etomidate Small molecule 1.5 mg/kg —
Background Fentanyl Other / unclassified 4 ug/kg —
Background Fentanyl Other / unclassified 5 ug/kg —
Background Midazolam Small molecule 0.05 mg/kg —
Background Propofol Small molecule 4 mg/kg —
Background Propofol Small molecule 8 mg/kg —
Background Remifentanil Small molecule 0.1 ug/kg —
Background Remifentanil Small molecule 0.2 ug/kg —
Background Sevoflurane Other / unclassified 0.6 % Inhaled
Background Sevoflurane Other / unclassified 1 % Inhaled

Indications

No indication recorded.